SLC6A3 and Parkinson disease: Additionally, there are certain biomarkers and risk factors are associated with prodromal PD including genetic predisposition, decrease dopamine transporter binding, which can be detected through neuroimaging, and presence of α-synuclein in peripheral tissues [14].